Learn More
Medchemexpress LLC L-threonine, N-[[[(1S)-3-amino-1-[3-[(1R)-1-amino-2-hydroxyethyl]-1,2,4-oxadiazol-5-yl]-3-oxopropyl)amino]carbonyl]- | 1673534-76-3 | 99.4% | 360.32 g·mol⁻¹ | C12H20N6O7 | 25 MG

Supplier: Medchemexpress LLC HY10109325MG
CA-170 is a small-molecule, orally active dual inhibitor of the immune checkpoints VISTA and PD-L1, used as a research reagent to modulate immune responses in preclinical immunology and oncology studies. It has been shown to restore T-cell proliferation and effector functions inhibited by PD-L1 and VISTA and is supplied as a powder for laboratory use.
- Oral small-molecule dual inhibitor of VISTA and PD-L1.
- Restores T-cell proliferation and effector function in inhibited systems.
- Suitable for in vitro and in vivo preclinical research applications.
- High purity by HPLC (approximately 99.4%).
- Molecular weight 360.32 g·mol⁻¹; formula C12H20N6O7.
- Supplied as a powder with recommended cold-storage conditions.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.